News

AroCell TK 210 ELISA can now be used on automated platforms

Oct 28, 2020

Quantification of Thymidine Kinase 1 in serum with AroCell TK 210 ELISA is now validated for use on an open automation platform for ELISA. This enhances the application and use of the assay.

We have now validated AroCell TK 210 ELISA for use on an automation platform, the Crocodile 5-in-1 ELISA mini workstation. This confirms that our product can both be used in manual operation as well as in automated operation mode. AroCell TK 210 ELISA shows similar high performance in terms of precision and sensitivity when used in this automated system as when run in manual mode, providing maximum flexibility for our customers.

Using AroCell TK 210 ELISA on an automation platform makes it easier than ever to measure levels of Thymidine kinase 1 (TK1) in blood samples (serum or Lithium-heparin plasma) for clinical use or in cell culture and xenografts models during drug development. AroCell TK 210 ELISA measures the concentration of TK1 by immunoassay and detects both active and inactive TK1, does not cross-react with TK2, or with non-human TK1.

Read more about AroCell TK 210 ELISA

Presentation at LabRoots 2024

Martin Shaw, Business Development at AroCell, held a presentation on the Thymidine Kinase 1 immunoassay, highlighting its significance as a valuable translational biomarker from drug discovery through to clinical trials. You can see the presentation below....

read more